Skip to main content

Table 4 Prevalence of respiratory symptoms and drug-related adverse events one week after discharge in children randomized to aerosolized racemic epinephrine or salbutamol during their hospital stay for bronchiolitis.

From: Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]

Clinical event as reported by parent or guardian

Percentage of children with symptom at one week post-discharge phone call (absolute numbers)*

P value for comparison of proportions

 

Racemic epinephrine

Salbutamol

 

Breathing difficulty

20.00 (6/30)

19.4 (6/31)

1.00

Wheezing

56.7 (17/30)

67.7 (21/31)

0.43

Chest retractions

13.3 (4/30)

25.8 (8/31)

0.33

Feeding pattern:

   

   Normal feeding

50 (15/30)

54.8 (17/31)

0.80

   Less than normal

50 (15/30)

41.9 (13/31)

0.61

   Unable to feed

0 (0/31)

3.2 (1/31)

1.00

Vomiting

20 (6/30)

35.5 (11/31)

0.25

Tremors

0 (0/31)

0 (0/31)

N/A

Pallor

13.3 (4/30)

6.5 (2/31)

0

Has had a visit to a physician

23.3 (7/30)

19.4 (6/31)

0.42

Has visited an emergency department or been hospitalized

3.3 (1/30)

3.2 (1/31)

1.00

  1. N/A = not applicable; * Not mutually exclusive